A pharmaceutical company has been involved in the development of oncological drugs from MUNI
Artios Pharma Ltd. and Merck KGaA recently announced a three-year research collaboration aimed at discovering and developing new cancer drugs. This collaborative agreement will also make use of results gained through cooperation with Kamil Paruch and Lumír Krejčí research groups.